Oak Thistle LLC Invests $50,000 in PetMed Express, Inc. (NASDAQ:PETS)

Oak Thistle LLC purchased a new position in shares of PetMed Express, Inc. (NASDAQ:PETS) in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 10,502 shares of the company’s stock, valued at approximately $50,000.

Several other institutional investors and hedge funds also recently made changes to their positions in PETS. CWM LLC grew its stake in shares of PetMed Express by 167.5% during the 4th quarter. CWM LLC now owns 3,378 shares of the company’s stock worth $26,000 after acquiring an additional 2,115 shares during the period. Nisa Investment Advisors LLC bought a new position in PetMed Express in the 4th quarter worth about $36,000. Quest Partners LLC bought a new position in PetMed Express in the 4th quarter worth about $47,000. HTLF Bank bought a new position in PetMed Express in the 4th quarter worth about $156,000. Finally, Virtu Financial LLC bought a new position in PetMed Express in the 4th quarter worth about $188,000. Institutional investors own 73.33% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on the company. Morgan Stanley cut their target price on PetMed Express from $6.50 to $3.50 and set an “underweight” rating for the company in a research note on Wednesday, June 12th. Lake Street Capital decreased their price objective on PetMed Express from $9.00 to $7.00 and set a “buy” rating on the stock in a report on Wednesday, June 12th.

PetMed Express Price Performance

NASDAQ:PETS opened at $4.04 on Tuesday. PetMed Express, Inc. has a fifty-two week low of $3.92 and a fifty-two week high of $15.08. The business has a 50 day moving average price of $4.23 and a 200-day moving average price of $5.23.

PetMed Express (NASDAQ:PETS) last released its quarterly earnings data on Monday, April 15th. The company reported ($0.10) earnings per share for the quarter. The company had revenue of $65.32 million for the quarter. PetMed Express had a negative net margin of 2.85% and a negative return on equity of 7.09%. As a group, research analysts forecast that PetMed Express, Inc. will post -0.28 earnings per share for the current year.

PetMed Express Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.